
Medolway Life Sciences Private Limited
About Medolway Life Sciences Private Limited
Data last updated:
Medolway Life Sciences Private Limited is a private limited company based in Ambala Cantt, Haryana, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 12 September 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U74999HR2017PTC070743. Its GSTIN is 06AAZCS2131A1ZJ (Haryana).
The company has an authorised share capital of ₹50,000 and a paid-up capital of ₹50,000. It was formerly known as Crisol Life Sciences Private Limited and Solwaymed Biotech Private Limited. It is led by directors Pardeep Kumar and Ishant Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at #25 – 26 Luxmipura Ambala Cantt, Haryana, India – 133001.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.47 Cr, a decline of 12% compared to the previous year. For the same year it recorded a net profit of ₹4.71 Lakh (net margin 0.9%) and EBITDA of ₹7.39 Lakh (EBITDA margin 1.4%). Revenue has grown at a compounded annual rate (CAGR) of 57% over three years and 66% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Name history
Medolway Life Sciences has undergone 2 name changes throughout its history. The company was previously known as Crisol Life Sciences Private Limited, and Solwaymed Biotech Private Limited. The current legal name is Medolway Life Sciences Private Limited.
| Company Name | Status |
|---|---|
| Medolway Life Sciences Private Limited | Current |
| Crisol Life Sciences Private Limited | Previous |
| Solwaymed Biotech Private Limited | Previous |
Contact details
Medolway Life Sciences Private Limited's registered office is in Ambala Cantt, Haryana. Its e-mail address is in the company report.
- Email
- Registered Address#25 – 26 Luxmipura Ambala Cantt, Haryana, India – 133001
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
To see the full contact details of Medolway Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medolway Life Sciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Medolway Life Sciences Private Limited, buy the company report.
Financials of Medolway Life Sciences Private Limited
FY 2025 filings availableMedolway Life Sciences Private Limited reported revenue of ₹5.47 Cr (down 12% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 12% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 66%. EBITDA fell 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.39 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.71 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.4% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medolway Life Sciences Private Limited, buy the company report.
Board of directors of Medolway Life Sciences Private Limited
Medolway Life Sciences has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pardeep Kumar | Director | 12 Sep 2017 | 9 Years 2 Months | Current |
| Ishant Sharma | Director | 12 Sep 2017 | 9 Years 2 Months | Current |
Peer comparison
Medolway Life Sciences Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Contract Research, Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Emdrix Pharmaceuticals Private Limited | ₹5.48 Cr (FY 2017) | 73.0% | Bangalore, Karnataka, India | |||
| Pee Vee Products Private Limited | ₹5.48 Cr (FY 2025) | 14.0% | Ahmedabad, Gujarat, India | |||
| Genome Therapeutics Private Limited | ₹5.47 Cr (FY 2025) | 14.0% | Secunderabad, Telangana, India | |||
| Medolway Life Sciences Private Limitedthis company | ₹5.47 Cr (FY 2025) | ₹4.71 Lakh | 0.9% | -12.0% | Ambala Cantt, Haryana, India |
To see the full peer comparison of Medolway Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Medolway Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medolway Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Medolway Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAZCS2131A1ZJ | Haryana | Active | 21 Sep 2017 |
To see the full GST registrations and return filing status of Medolway Life Sciences Private Limited, buy the company report.
Recent activity
Medolway Life Sciences Private Limited has 4 board changes on record since 2017: 3 appointments and 1 cessation. The latest: Arun Kumar ceased to be Director on 24 Mar 2022.
Frequently asked questions
Medolway Life Sciences is an active private limited company based in Ambala Cantt, Haryana, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 12 September 2017 (9+ years old) and is registered under CIN U74999HR2017PTC070743.
Medolway Life Sciences has 2 current directors:
- Pardeep Kumar - Director
- Ishant Sharma - Director
The latest financial statements of Medolway Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Medolway Life Sciences is 06AAZCS2131A1ZJ, registered in Haryana.
The CIN (Corporate Identification Number) of Medolway Life Sciences is U74999HR2017PTC070743. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medolway Life Sciences was incorporated on 12 September 2017, making it 9+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Medolway Life Sciences by revenue are Emdrix Pharmaceuticals Private Limited, Pee Vee Products Private Limited, Genome Therapeutics Private Limited, all in the Pharma industry (Contract Research, Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Arun Kumar ceased to be Director on 24 Mar 2022. Arun Kumar was appointed as Director on 12 Sep 2017. Ishant Sharma was appointed as Director on 12 Sep 2017. Medolway Life Sciences has 4 board changes on record in total.
The registered office of Medolway Life Sciences is at #25 – 26 Luxmipura Ambala Cantt, Haryana, India – 133001.
Medolway Life Sciences operates in the business services industry, in the miscellaneous business activities segment.
The compliance status of Medolway Life Sciences is compliant as of 05 July 2026. The company is actively filing with the Registrar of Companies.

